Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow.
JSON
Publications
Lazarevic V, Orsmark-Pietras C, Lilljebjörn H, Pettersson L, Rissler M, Lübking A, Ehinger M, Juliusson G, Fioretos T
Blood 131 (5) 577-581 [2018-02-01; online 2017-11-30]
Clinical Genomics Lund [Collaborative]
QC bibliography QC xrefs
PubMed 29191917
DOI 10.1182/blood-2017-07-793620
Crossref 10.1182/blood-2017-07-793620
pii: S0006-4971(20)32516-7